JOHN ABALLI - 24 Feb 2026 Form 4 Insider Report for EXAGEN INC. (XGN)

Role
President and CEO, Director
Signature
/s/ Jeffrey G. Black, as attorney-in-fact
Issuer symbol
XGN
Transactions as of
24 Feb 2026
Net transactions value
-$41,262
Form type
4
Filing time
25 Feb 2026, 19:11:33 UTC
Previous filing
20 Oct 2025
Next filing
04 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
ABALLI JOHN President and CEO, Director C/O EXAGEN INC., 1261 LIBERTY WAY, VISTA /s/ Jeffrey G. Black, as attorney-in-fact 25 Feb 2026 0001843113

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XGN Common Stock Sale $41,262 -11,430 -1.6% $3.61 702,997 24 Feb 2026 Direct F1
holding XGN Common Stock 40,401 24 Feb 2026 by Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale reported on this Form 4 represents shares sold by the Reporting Person, at the direction of the Issuer, to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated solely by the Issuer and does not represent a discretionary transaction by the Reporting Person.